MorphoSys AG

MOR NASDAQ
29.03
+1.12
+4.01%
交易中 12:10 07/23 EDT
开盘
29.00
昨收
27.91
最高
29.14
最低
28.86
成交量
12.49万
成交均量(3M)
8.10万
52周最高
35.90
52周最低
21.75
换手率
0.10%
市值
36.65亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供MorphoSys AG MOR股票价格,MorphoSys AG股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. The Company's operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery segment, the Company applies technologies for the research, development and optimization of therapeutic antibodies as drug candidates. The Company develops new treatments for patients suffering from serious diseases. Its technologies include HuCAL, which is a collection fully human antibodies and a system for their optimization; Ylanthia, which is an antibody library in Fab format, and Slonomics, an automated technology for gene synthesis and modification for the generation of gene libraries in a controlled process.
展开 >

最近浏览

名称
价格
涨跌幅